Long-term safety and efficacy of long-acting pasireotide in acromegaly

被引：0
|
作者：
Amit Akirov
Alexander Gorshtein
Idit Dotan
Nariman Saba Khazen
Yulia Pauker
Michal Gershinsky
Ilan Shimon
机构：
[1] Beilinson Hospital,Institute of Endocrinology
[2] Tel-Aviv University,Sackler School of Medicine
[3] Clalit Medical Services,Linn Medical Center
来源：
Endocrine | 2021年 / 74卷
关键词：
Acromegaly; Growth hormone; Hyperglycemia; Pasireotide LAR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：396 / 403
页数：7
相关论文
共 50 条
  • [1] Long-term safety and efficacy of long-acting pasireotide in acromegaly
    Akirov, Amit
    Gorshtein, Alexander
    Dotan, Idit
    Khazen, Nariman Saba
    Pauker, Yulia
    Gershinsky, Michal
    Shimon, Ilan
    ENDOCRINE, 2021, 74 (02) : 396 - 403
  • [2] Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
    Neggers, S. J. C. M. M.
    Franck, S. E.
    de Rooij, F. W. M.
    Dallenga, A. H. G.
    Poublon, R. M. L.
    Feelders, R. A.
    Janssen, J. A. M. J. L.
    Buchfelder, M.
    Hofland, L. J.
    Jorgensen, J. O. L.
    van der Lely, A. J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10): : 3644 - 3652
  • [3] Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly
    Ayuk, J
    Stewart, SE
    Stewart, PM
    Sheppard, MC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09): : 4142 - 4146
  • [4] Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study
    Shimon, Ilan
    Adnan, Zaina
    Gorshtein, Alexander
    Baraf, Lior
    Khazen, Nariman Saba
    Gershinsky, Michal
    Pauker, Yulia
    Abid, Ali
    Niven, Mark J.
    Shechner, Carmela
    Greenman, Yona
    ENDOCRINE, 2018, 62 (02) : 448 - 455
  • [5] Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study
    Ilan Shimon
    Zaina Adnan
    Alexander Gorshtein
    Lior Baraf
    Nariman Saba Khazen
    Michal Gershinsky
    Yulia Pauker
    Ali Abid
    Mark J Niven
    Carmela Shechner
    Yona Greenman
    Endocrine, 2018, 62 : 448 - 455
  • [6] LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING ANALOG OF SOMATOSTATIN
    CHNG, LJC
    SANDLER, LM
    KRAENZLIN, ME
    BURRIN, JM
    JOPLIN, GF
    BLOOM, SR
    BRITISH MEDICAL JOURNAL, 1985, 290 (6464): : 284 - 285
  • [7] Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients
    Kissling, Werner
    Glue, Per
    Medori, Rossella
    Simpson, Steve
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2007, 22 (08) : 505 - 513
  • [8] LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING ANALOG OF SOMATOSTATIN, OCTREOTIDE
    PAGE, MD
    MILLWARD, ME
    TAYLOR, A
    PREECE, M
    HOURIHAN, M
    HALL, R
    SCANLON, MF
    QUARTERLY JOURNAL OF MEDICINE, 1990, 74 (274): : 189 - 201
  • [9] Long-term safety of long-acting risperidone microspheres
    Eerdekens, M
    Fleischhacker, WW
    Xie, Y
    Gefvert, O
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 174 - 174
  • [10] Long-term safety of long-acting risperidone microspheres
    Eerdekens, M
    Fleischhacker, WW
    Yang, X
    Beauclair, L
    Sauret, H
    Chrzanowski, W
    Martin, S
    Gefvert, O
    EUROPEAN PSYCHIATRY, 2002, 17 : 193S - 193S
12345